Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 231

1.

Author response: Quality of life predicts outcome of deep brain stimulation in early Parkinson disease.

Deuschl G, Schuepbach MWM, Schade-Brittinger C, Tonder L, Krack P.

Neurology. 2020 Mar 3;94(9):413. doi: 10.1212/WNL.0000000000009045. No abstract available.

PMID:
32123062
2.

Interplay of Pisa syndrome and scoliosis in individuals with Parkinson's disease treated with bilateral stimulation of subthalamic nuclei: IPOLAP study.

Pérennou D, Jaeger M, Debu B, Fraix V, Marquer A, Krack P, Piscicelli C, Castrioto A.

Ann Phys Rehabil Med. 2020 Mar 5. pii: S1877-0657(20)30035-X. doi: 10.1016/j.rehab.2020.02.001. [Epub ahead of print] No abstract available.

PMID:
32061769
3.

Subthalamic nucleus activity dynamics and limb movement prediction in Parkinson's disease.

Khawaldeh S, Tinkhauser G, Shah SA, Peterman K, Debove I, Nguyen TAK, Nowacki A, Lachenmayer ML, Schuepbach M, Pollo C, Krack P, Woolrich M, Brown P.

Brain. 2020 Feb 1;143(2):582-596. doi: 10.1093/brain/awz417.

4.

Association of Rare Genetic Variants in Opioid Receptors with Tourette Syndrome.

Depienne C, Ciura S, Trouillard O, Bouteiller D, Leitão E, Nava C, Keren B, Marie Y, Guegan J, Forlani S, Brice A, Anheim M, Agid Y, Krack P, Damier P, Viallet F, Houeto JL, Durif F, Vidailhet M, Worbe Y, Roze E, Kabashi E, Hartmann A.

Tremor Other Hyperkinet Mov (N Y). 2019 Nov 22;9. doi: 10.7916/tohm.v0.693. eCollection 2019.

5.

Deep Brain Stimulation for Freezing of Gait in Parkinson's Disease With Early Motor Complications.

Barbe MT, Tonder L, Krack P, Debû B, Schüpbach M, Paschen S, Dembek TA, Kühn AA, Fraix V, Brefel-Courbon C, Wojtecki L, Maltête D, Damier P, Sixel-Döring F, Weiss D, Pinsker M, Witjas T, Thobois S, Schade-Brittinger C, Rau J, Houeto JL, Hartmann A, Timmermann L, Schnitzler A, Stoker V, Vidailhet M, Deuschl G; EARLYSTIM study group.

Mov Disord. 2020 Jan;35(1):82-90. doi: 10.1002/mds.27892. Epub 2019 Nov 22.

PMID:
31755599
6.

Deep Brain Stimulation in Movement Disorders: From Experimental Surgery to Evidence-Based Therapy.

Krack P, Volkmann J, Tinkhauser G, Deuschl G.

Mov Disord. 2019 Dec;34(12):1795-1810. doi: 10.1002/mds.27860. Epub 2019 Oct 3.

PMID:
31580535
7.

Dyskinesia-inducing lead contacts optimize outcome of subthalamic stimulation in Parkinson's disease.

Bouthour W, Béreau M, Kibleur A, Zacharia A, Tomkova Chaoui E, Fleury V, Benis D, Momjian S, Bally J, Lüscher C, Krack P, Burkhard PR.

Mov Disord. 2019 Nov;34(11):1728-1734. doi: 10.1002/mds.27853. Epub 2019 Sep 30.

PMID:
31571277
8.

Effects of bilateral stimulation of the subthalamic nucleus in Parkinson's disease with and without REM sleep behaviour disorder.

Bargiotas P, Debove I, Bargiotas I, Lachenmayer ML, Ntafouli M, Vayatis N, Schüpbach MW, Krack P, Bassetti CL.

J Neurol Neurosurg Psychiatry. 2019 Dec;90(12):1310-1316. doi: 10.1136/jnnp-2019-320858. Epub 2019 Aug 17.

PMID:
31422368
9.

Acute lethargy after abrupt apomorphine withdrawal in Parkinson's disease.

Cavallieri F, Fraix V, Meoni S, Krack P, Moro E, Castrioto A.

J Neurol Sci. 2019 Sep 15;404:44-46. doi: 10.1016/j.jns.2019.07.011. Epub 2019 Jul 10. No abstract available.

PMID:
31325667
10.

Early limbic microstructural alterations in apathy and depression in de novo Parkinson's disease.

Prange S, Metereau E, Maillet A, Lhommée E, Klinger H, Pelissier P, Ibarrola D, Heckemann RA, Castrioto A, Tremblay L, Sgambato V, Broussolle E, Krack P, Thobois S.

Mov Disord. 2019 Nov;34(11):1644-1654. doi: 10.1002/mds.27793. Epub 2019 Jul 15.

PMID:
31309609
11.

Programming parameters of subthalamic deep brain stimulators in Parkinson's disease from a controlled trial.

Knudsen K, Krack P, Tonder L, Houeto JL, Rau J, Schade-Brittinger C, Hartmann A, Hälbig TD, Paschen S, Barbe MT, Kühn A, Fraix V, Brefel-Courbon C, Vesper J, Maltête D, Sixel-Döring F, Weiss D, Witjas T, Thobois S, Agid Y, Schnitzler A, Schuepbach WMM, Timmermann L, Damier P, Vidailhet M, Deuschl G; EARLYSTIM study group.

Parkinsonism Relat Disord. 2019 Aug;65:217-223. doi: 10.1016/j.parkreldis.2019.05.023. Epub 2019 Jun 18.

PMID:
31257096
12.

Scales to assess impulsive and compulsive behaviors in Parkinson's disease: Critique and recommendations.

Evans AH, Okai D, Weintraub D, Lim SY, O'Sullivan SS, Voon V, Krack P, Sampaio C, Post B, Leentjens AFG, Martinez-Martin P, Stebbins GT, Goetz CG, Schrag A; Members of the International Parkinson and Movement Disorder Society (IPMDS) Rating Scales Review Committee.

Mov Disord. 2019 Jun;34(6):791-798. doi: 10.1002/mds.27689. Epub 2019 May 28. Review.

PMID:
31136681
13.

Directional stimulation of subthalamic nucleus sweet spot predicts clinical efficacy: Proof of concept.

Nguyen TAK, Nowacki A, Debove I, Petermann K, Tinkhauser G, Wiest R, Schüpbach M, Krack P, Pollo C.

Brain Stimul. 2019 Sep - Oct;12(5):1127-1134. doi: 10.1016/j.brs.2019.05.001. Epub 2019 May 17.

PMID:
31130498
14.

Suicide and suicide attempts after subthalamic nucleus stimulation in Parkinson disease.

Giannini G, Francois M, Lhommée E, Polosan M, Schmitt E, Fraix V, Castrioto A, Ardouin C, Bichon A, Pollak P, Benabid AL, Seigneuret E, Chabardes S, Wack M, Krack P, Moro E.

Neurology. 2019 Jul 2;93(1):e97-e105. doi: 10.1212/WNL.0000000000007665. Epub 2019 May 17.

PMID:
31101738
15.

Shame in Parkinson'S Disease: A Review.

Angulo J, Fleury V, Péron JA, Penzenstadler L, Zullino D, Krack P.

J Parkinsons Dis. 2019;9(3):489-499. doi: 10.3233/JPD-181462.

16.

Author Correction: Biomarkers for closed-loop deep brain stimulation in Parkinson disease and beyond.

Bouthour W, Mégevand P, Donoghue J, Lüscher C, Birbaumer N, Krack P.

Nat Rev Neurol. 2019 Jun;15(6):363. doi: 10.1038/s41582-019-0189-x.

PMID:
30992557
17.

Long-term effects of subthalamic stimulation in Obsessive-Compulsive Disorder: Follow-up of a randomized controlled trial.

Mallet L, Du Montcel ST, Clair AH, Arbus C, Bardinet E, Baup N, Chabardès S, Chéreau I, Czernecki V, Fontaine D, Harika-Germaneau G, Haynes WI, Houeto JL, Jaafari N, Krack P, Millet B, Navarro S, Polosan M, Pelissolo A, Welter ML; STOC Long-term Study Group.

Brain Stimul. 2019 Jul - Aug;12(4):1080-1082. doi: 10.1016/j.brs.2019.04.004. Epub 2019 Apr 9. No abstract available.

18.

Biomarkers for closed-loop deep brain stimulation in Parkinson disease and beyond.

Bouthour W, Mégevand P, Donoghue J, Lüscher C, Birbaumer N, Krack P.

Nat Rev Neurol. 2019 Jun;15(6):343-352. doi: 10.1038/s41582-019-0166-4. Erratum in: Nat Rev Neurol. 2019 Apr 16;:.

PMID:
30936569
19.

Apathy in Parkinson's disease with REM sleep behavior disorder.

Bargiotas P, Ntafouli M, Lachenmayer ML, Krack P, Schüpbach WMM, Bassetti CLA.

J Neurol Sci. 2019 Apr 15;399:194-198. doi: 10.1016/j.jns.2019.02.028. Epub 2019 Feb 20.

PMID:
30826716
20.

Quality of life predicts outcome of deep brain stimulation in early Parkinson disease.

Schuepbach WMM, Tonder L, Schnitzler A, Krack P, Rau J, Hartmann A, Hälbig TD, Pineau F, Falk A, Paschen L, Paschen S, Volkmann J, Dafsari HS, Barbe MT, Fink GR, Kühn A, Kupsch A, Schneider GH, Seigneuret E, Fraix V, Kistner A, Chaynes PP, Ory-Magne F, Brefel-Courbon C, Vesper J, Wojtecki L, Derrey S, Maltête D, Damier P, Derkinderen P, Sixel-Döring F, Trenkwalder C, Gharabaghi A, Wächter T, Weiss D, Pinsker MO, Regis JM, Witjas T, Thobois S, Mertens P, Knudsen K, Schade-Brittinger C, Houeto JL, Agid Y, Vidailhet M, Timmermann L, Deuschl G; EARLYSTIM study group.

Neurology. 2019 Mar 5;92(10):e1109-e1120. doi: 10.1212/WNL.0000000000007037. Epub 2019 Feb 8. Erratum in: Neurology. 2019 Jun 11;92(24):1166.

21.

Affective modulation of the associative-limbic subthalamic nucleus: deep brain stimulation in obsessive-compulsive disorder.

Polosan M, Droux F, Kibleur A, Chabardes S, Bougerol T, David O, Krack P, Voon V.

Transl Psychiatry. 2019 Feb 4;9(1):73. doi: 10.1038/s41398-019-0404-y.

22.

The Pioneering and Unknown Stereotactic Approach of Roeder and Orthner from Göttingen. Part II: Long-Term Outcome and Postmortem Analysis of Bilateral Pallidotomy in the Pre-Levodopa Era.

Hamel W, Köppen JA, Müller D, Hariz M, Moll CKE, Krack P.

Stereotact Funct Neurosurg. 2018;96(6):353-363. doi: 10.1159/000495412. Epub 2019 Jan 16. Review.

23.

Wait and you shall see: sexual delay discounting in hypersexual Parkinson's disease.

Girard R, Obeso I, Thobois S, Park SA, Vidal T, Favre E, Ulla M, Broussolle E, Krack P, Durif F, Dreher JC.

Brain. 2019 Jan 1;142(1):146-162. doi: 10.1093/brain/awy298.

PMID:
30590514
24.

Suggestive association between OPRM1 and impulse control disorders in Parkinson's disease.

Cormier-Dequaire F, Bekadar S, Anheim M, Lebbah S, Pelissolo A, Krack P, Lacomblez L, Lhommée E, Castrioto A, Azulay JP, Defebvre L, Kreisler A, Durif F, Marques-Raquel A, Brefel-Courbon C, Grabli D, Roze E, Llorca PM, Ory-Magne F, Benatru I, Ansquer S, Maltête D, Tir M, Krystkowiak P, Tranchant C, Lagha-Boukbiza O, Lebrun-Vignes B, Mangone G, Vidailhet M, Charbonnier-Beaupel F, Rascol O, Lesage S, Brice A, Tezenas du Montcel S, Corvol JC; BADGE-PD study group.

Mov Disord. 2018 Dec;33(12):1878-1886. doi: 10.1002/mds.27519. Epub 2018 Nov 16.

PMID:
30444952
25.

The Neuropsychiatric Fluctuations Scale for Parkinson's Disease: A Pilot Study.

Schmitt E, Krack P, Castrioto A, Klinger H, Bichon A, Lhommée E, Pelissier P, Fraix V, Thobois S, Moro E, Martinez-Martin P.

Mov Disord Clin Pract. 2018 Mar 23;5(3):265-272. doi: 10.1002/mdc3.12607. eCollection 2018 May-Jun.

26.

Different effects of levodopa and subthalamic stimulation on emotional conflict in Parkinson's disease.

Martínez-Fernández R, Kibleur A, Chabardès S, Fraix V, Castrioto A, Lhommée E, Moro E, Lescoules L, Pelissier P, David O, Krack P.

Hum Brain Mapp. 2018 Dec;39(12):5014-5027. doi: 10.1002/hbm.24341. Epub 2018 Sep 26.

PMID:
30259598
27.

Hyperdopaminergic behavioral spectrum in Parkinson's disease: A review.

Béreau M, Fleury V, Bouthour W, Castrioto A, Lhommée E, Krack P.

Rev Neurol (Paris). 2018 Nov;174(9):653-663. doi: 10.1016/j.neurol.2018.07.005. Epub 2018 Sep 14. Review.

PMID:
30224159
28.

Crime and Parkinson's: The jury is out.

Santens P, De Letter M, Lees AJ, Krack P, van den Heuvel OA, Bloem BR.

Mov Disord. 2018 Jul;33(7):1092-1094. doi: 10.1002/mds.27436. No abstract available.

PMID:
30153392
29.

Interventions to Reduce Over-Utilized Tests and Treatments in Bronchiolitis.

Tyler A, Krack P, Bakel LA, O'Hara K, Scudamore D, Topoz I, Freeman J, Moss A, Allen R, Swanson A, Bajaj L.

Pediatrics. 2018 Jun;141(6). pii: e20170485. doi: 10.1542/peds.2017-0485. Epub 2018 May 11.

30.

[Movement disorders emergencies].

Burkhard PR, Horvath J, Fleury V, Zacharia A, Bally JF, Bereau M, Bouthour W, Lüscher C, Krack P.

Rev Med Suisse. 2018 Apr 25;14(604):888-891. French.

PMID:
29701435
31.

[Advanced Parkinson's disease : indication for complex treatments].

Béreau M, Tomkova E, Zacharia A, Bouthour W, Fleury V, Bally JF, Horvath J, Momjian S, Lüscher C, Burkhard P, Krack P.

Rev Med Suisse. 2018 Apr 25;14(604):875-878. French.

PMID:
29701432
32.

Dissociable Effects of Subthalamic Stimulation in Obsessive Compulsive Disorder on Risky Reward and Loss Prospects.

Voon V, Droux F, Chabardes S, Bougerol T, Kohl S, David O, Krack P, Polosan M.

Neuroscience. 2018 Jul 1;382:105-114. doi: 10.1016/j.neuroscience.2018.03.010. Epub 2018 Mar 17.

PMID:
29559386
33.

Behavioural outcomes of subthalamic stimulation and medical therapy versus medical therapy alone for Parkinson's disease with early motor complications (EARLYSTIM trial): secondary analysis of an open-label randomised trial.

Lhommée E, Wojtecki L, Czernecki V, Witt K, Maier F, Tonder L, Timmermann L, Hälbig TD, Pineau F, Durif F, Witjas T, Pinsker M, Mehdorn M, Sixel-Döring F, Kupsch A, Krüger R, Elben S, Chabardès S, Thobois S, Brefel-Courbon C, Ory-Magne F, Regis JM, Maltête D, Sauvaget A, Rau J, Schnitzler A, Schüpbach M, Schade-Brittinger C, Deuschl G, Houeto JL, Krack P; EARLYSTIM study group.

Lancet Neurol. 2018 Mar;17(3):223-231. doi: 10.1016/S1474-4422(18)30035-8.

PMID:
29452685
34.

Subthalamic stimulation and neuropsychiatric symptoms in Parkinson's disease: results from a long-term follow-up cohort study.

Abbes M, Lhommée E, Thobois S, Klinger H, Schmitt E, Bichon A, Castrioto A, Xie J, Fraix V, Kistner A, Pélissier P, Seigneuret É, Chabardès S, Mertens P, Broussolle E, Moro E, Krack P.

J Neurol Neurosurg Psychiatry. 2018 Aug;89(8):836-843. doi: 10.1136/jnnp-2017-316373. Epub 2018 Feb 7.

PMID:
29436490
35.

Postoperative rehabilitation after deep brain stimulation surgery for movement disorders.

Allert N, Cheeran B, Deuschl G, Barbe MT, Csoti I, Ebke M, Glaser M, Kang JS, Kelm S, Krack P, Kroth J, Jobst U, Leisse M, Oliviero A, Nolte PN, Quick-Weller J, Strothjohann M, Tamás G, Werner M, Muthuraman M, Volkmann J, Fasano A, Groppa S.

Clin Neurophysiol. 2018 Mar;129(3):592-601. doi: 10.1016/j.clinph.2017.12.035. Epub 2018 Jan 10. Review.

PMID:
29414403
36.

[Obsessive compulsive disorder and deep brain stimulation, a future so close].

Flores Alves Dos Santos J, Krack P, Momjian S, Bondolfi G, Mallet L.

Rev Med Suisse. 2018 Feb 7;14(593):327-330. French.

PMID:
29412526
37.

Historical crossroads in the conceptual delineation of apathy in Parkinson's disease.

Prange S, Pagonabarraga J, Krack P, Kulisevsky J, Sgambato V, Tremblay L, Thobois S, Broussolle E.

Brain. 2018 Feb 1;141(2):613-619. doi: 10.1093/brain/awx362. No abstract available.

PMID:
29329378
38.

Apathy in idiopathic normal pressure hydrocephalus: A marker of reversible gait disorders.

Allali G, Laidet M, Armand S, Saj A, Krack P, Assal F.

Int J Geriatr Psychiatry. 2018 May;33(5):735-742. doi: 10.1002/gps.4847. Epub 2018 Jan 2.

PMID:
29292530
39.

Short pulse width in subthalamic stimulation in Parkinson's disease: a randomized, double-blind study.

Bouthour W, Wegrzyk J, Momjian S, Péron J, Fleury V, Tomkova Chaoui E, Horvath J, Boëx C, Lüscher C, Burkhard PR, Krack P, Zacharia A.

Mov Disord. 2018 Jan;33(1):169-173. doi: 10.1002/mds.27265. Epub 2017 Dec 21.

PMID:
29266392
40.

Reversing dopaminergic sensitization.

Castrioto A, Carnicella S, Fraix V, Chabardes S, Moro E, Krack P.

Mov Disord. 2017 Dec;32(12):1679-1683. doi: 10.1002/mds.27213. Epub 2017 Nov 18. Review. No abstract available.

PMID:
29150871
41.

Pallidal deep brain stimulation for dystonia: a long term study.

Meoni S, Fraix V, Castrioto A, Benabid AL, Seigneuret E, Vercueil L, Pollak P, Krack P, Chevrier E, Chabardes S, Moro E.

J Neurol Neurosurg Psychiatry. 2017 Nov;88(11):960-967. doi: 10.1136/jnnp-2016-315504. Epub 2017 Sep 28.

PMID:
28972096
42.

Thalamic deep brain stimulation for tremor in Parkinson disease, essential tremor, and dystonia.

Cury RG, Fraix V, Castrioto A, Pérez Fernández MA, Krack P, Chabardes S, Seigneuret E, Alho EJL, Benabid AL, Moro E.

Neurology. 2017 Sep 26;89(13):1416-1423. doi: 10.1212/WNL.0000000000004295. Epub 2017 Aug 2.

PMID:
28768840
43.

Psychostimulant effect of dopaminergic treatment and addictions in Parkinson's disease.

Delpont B, Lhommée E, Klinger H, Schmitt E, Bichon A, Fraix V, Castrioto A, Quesada JL, Pélissier P, Kistner A, Carnicella S, Lüscher C, Broussolle E, Pollak P, Thobois S, Krack P.

Mov Disord. 2017 Nov;32(11):1566-1573. doi: 10.1002/mds.27101. Epub 2017 Jul 24.

PMID:
28737225
44.

A deeply superficial brain stimulation.

Bouthour W, Krack P, Lüscher C.

Mov Disord. 2017 Sep;32(9):1326. doi: 10.1002/mds.27111. Epub 2017 Jul 22. No abstract available.

PMID:
28734052
45.

Personality, dopamine, and Parkinson's disease: Insights from subthalamic stimulation.

Lhommée E, Boyer F, Wack M, Pélissier P, Klinger H, Schmitt E, Bichon A, Fraix V, Chabardès S, Mertens P, Castrioto A, Kistner A, Broussolle E, Thobois S, Krack P.

Mov Disord. 2017 Aug;32(8):1191-1200. doi: 10.1002/mds.27065. Epub 2017 Jun 23.

PMID:
28643887
46.

To lesion or not to lesion: That was the question (Reply to "stereotactic ablative surgery does not just mean 'adding another lesion'").

Obeso JA, Martinez-Fernandez R, Del Álamo M, Krack P.

Mov Disord. 2017 Jul;32(7):1113-1114. doi: 10.1002/mds.27066. Epub 2017 Jun 14. No abstract available.

PMID:
28612948
47.

Author response: Long-term improvement in obsessions and compulsions with subthalamic stimulation.

Krack P, Polosan M, Chabardès S, Bougerol T, Ardouin C, Pollak P, Benabid AL.

Neurology. 2017 Apr 25;88(17):1684. doi: 10.1212/WNL.0000000000003878. No abstract available.

PMID:
28438846
48.

Current applications and limitations of surgical treatments for movement disorders.

Krack P, Martinez-Fernandez R, Del Alamo M, Obeso JA.

Mov Disord. 2017 Jan;32(1):36-52. doi: 10.1002/mds.26890. Review.

PMID:
28124435
49.

Decisional impulsivity and the associative-limbic subthalamic nucleus in obsessive-compulsive disorder: stimulation and connectivity.

Voon V, Droux F, Morris L, Chabardes S, Bougerol T, David O, Krack P, Polosan M.

Brain. 2017 Feb;140(2):442-456. doi: 10.1093/brain/aww309. Epub 2016 Dec 31.

50.

Apathy and higher level of gait control in normal pressure hydrocephalus.

Allali G, Laidet M, Armand S, Saj A, Krack P, Assal F.

Int J Psychophysiol. 2017 Sep;119:127-131. doi: 10.1016/j.ijpsycho.2016.12.002. Epub 2016 Dec 11.

PMID:
27965058

Supplemental Content

Support Center